Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | LLB Swiss Investment AGSociété | -3,85M | 100,79k | Vente | 0,03 | 41,15M | -8,55% |
| 2026-04-15 | Condire Investors, LLCSociété | 191,00M | 5,56M | Achat | 0,03 | 289,38M | 194,15% |
| 2026-04-15 | Canaccord Genuity Asset Management LimitedSociété | 65,63M | 0,00 | Achat | - | 112,63M | 139,63% |
| 2026-04-21 | Mr. Sam PazukiMD, CEO & Executive Director | -4,32M | 0,00 | Other Derivative Disposition | - | 4,31M | -50,09% |
| 2026-04-15 | Mr. Sam PazukiMD, CEO & Executive Director | 851,06k | 29,12k | Achat | 0,03 | 8,57M | 11,03% |
| 2026-04-21 | Mr. Sam PazukiMD, CEO & Executive Director | -1,47M | 0,00 | Other Derivative Disposition | - | 25,30M | -5,51% |
| 2026-04-16 | Cupel Advisory CorpSociété | 1 000,00k | 29,17k | Achat | 0,03 | 2,18M | 84,75% |
| 2026-04-16 | Mr. James Carr WithallIndependent Non-Executive Director | 350,00k | 10,21k | Achat | 0,03 | 1,35M | 35,00% |
| 2026-04-14 | Condire Investors, LLCSociété | 191,00M | 5,55M | Achat | 0,03 | 289,38M | 194,15% |
| 2026-04-15 | Franklin Resources, Inc.Société | 75,00M | 2,15M | Achat | 0,03 | 118,53M | 172,31% |
| 2026-04-14 | Nokomis Capital, L.L.C.Société | 135,00M | 3,85M | Achat | 0,03 | 135,00M | - |
| 2026-03-05 | Condire Investors, LLCSociété | 98,38M | 3,90M | Achat | 0,04 | 98,38M | - |
| 2024-12-10 | B2Gold Corp.Société | 27,00M | 860,14k | Achat | 0,03 | 31,01M | 673,27% |
| 2025-12-10 | Mr. Justin OsborneIndependent Non-Executive Chairman | 1 000,00k | 24,57k | Achat | 0,02 | 2,94M | 51,52% |
| 2025-12-10 | Cupel Advisory CorpSociété | 300,00k | 9,02k | Achat | 0,03 | 1,18M | 34,09% |
| 2025-12-10 | Mr. Justin OsborneIndependent Non-Executive Chairman | 1 000,00k | 24,57k | Achat | 0,02 | 2,79M | 55,84% |
| 2025-12-05 | Cupel Advisory CorpSociété | 200,00k | 6,49k | Achat | 0,03 | 880,00k | 29,41% |
| 2025-12-04 | Mr. Sam PazukiMD, CEO & Executive Director | 350,00k | 8,28k | Achat | 0,02 | 7,72M | 4,75% |
| 2025-12-03 | Mr. James Carr WithallIndependent Non-Executive Director | 500,00k | 14,34k | Achat | 0,03 | 1 000,00k | 100,00% |
| 2025-12-03 | Mr. Sam PazukiMD, CEO & Executive Director | 957,58k | 25,63k | Achat | 0,02 - 0,03 | 7,37M | 14,94% |
| 2025-10-23 | Mr. Sam PazukiMD, CEO & Executive Director | 1,08M | 76,91 | Derivative Exercise and Retained Stock | 0,00 | 6,41M | 20,34% |
| 2025-07-15 | LLB Swiss Investment AGSociété | 10,31M | 229,00k | Achat | 0,02 | 45,00M | 29,73% |
| 2025-05-23 | LLB Swiss Investment AGSociété | -822,06k | 18,72k | Vente | 0,02 | 45,00M | -1,79% |
| 2025-05-26 | LLB Swiss Investment AGSociété | -898,94k | 20,04k | Other Disposition | 0,02 | 45,00M | -1,96% |
| 2025-07-18 | Ms. Carol MarinkovichExecutive Director & Company Secretary | 540,88k | 0,00 | Derivative Exercise and Retained Stock | - | 865,39k | 166,68% |
| 2025-07-04 | Ms. Carol MarinkovichExecutive Director & Company Secretary | 540,88k | 10,98k | Derivative Exercise and Retained Stock | 0,02 | 324,50k | -249,97% |
| 2025-07-18 | Mr. Sam PazukiMD, CEO & Executive Director | 1,08M | 41,71k | Derivative Exercise and Retained Stock | 0,02 - 0,04 | 6,41M | 20,34% |
| 2025-07-04 | Mr. Ryan FinkelsteinCFO | 559,94k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,04 | 559,94k | - |
| 2025-07-04 | Mr. Ryan FinkelsteinCFO | 1,34M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,34M | - |
| 2025-07-04 | Cupel Advisory CorpSociété | 1,25M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,25M | - |
| 2025-07-07 | Mr. Michael Bethel SkeadPresident | 6,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,04 | 8,56M | 234,67% |
| 2025-07-04 | Mr. Sam PazukiMD, CEO & Executive Director | 3,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,04 | 26,78M | 12,62% |
| 2025-07-04 | Mr. Sam PazukiMD, CEO & Executive Director | 5,00M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 12,10M | 70,38% |
| 2025-07-04 | Ms. Carol MarinkovichExecutive Director & Company Secretary | 1,88M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-07-04 | Ms. Carol MarinkovichExecutive Director & Company Secretary | -1,03M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-07-04 | Mr. Sam PazukiMD, CEO & Executive Director | -4,37M | 0,00 | Other Derivative Disposition | - | - | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
